Taking Better Aim at Tumors

(DGIwire) – When it comes to treating cancer, chemotherapy and immunotherapy have proven to be powerful within certain limits. Take immunotherapy: Despite its great promise, it doesn’t help every patient to which it is given—and its track record of success is uneven among different cancers. So notes Douglas J. Swirsky, President and CEO of Rexahn […]

What’s Next in the Fight Against Pancreatic Cancer?

(DGIwire) – Sobering news from the world of medicine: More than 56,000 Americans will be diagnosed with pancreatic cancer in 2019, according to a recent estimate by the American Cancer Society. This represents a two percent increase over the previous year’s diagnoses. While the ACS also states that the disease’s five-year survival rate continues to […]

Why the Future of Cancer Immunotherapy Looks Bright

(DGIwire) – Cancer immunotherapy is a field of medicine that aims to identify treatments for cancer by enhancing the human body’s immune response. According to a recent review article in Frontiers of Immunology, this form of treatment has witnessed a surge in interest in recent years and is likely to transform the treatment of many […]

What’s Best for Breast Cancer: The Possibilities of Enhancing Immunotherapy

(DGIwire) – Could the advent of immunotherapy mean a brighter future for breast cancer treatment? As recently noted in an article in TIME magazine, many researchers think it might. They have set their sights on finding ways to retrain the body to recognize and destroy tumor cancer cells—a strategy that is making immune-based treatments the […]

Triple-Negative Breast Cancer: 5 Questions to Ask

(DGIwire) – Certain types of breast cancer have more treatment options than others with today’s standard of care. Anyone who has been diagnosed with one variant of this disease—known as triple-negative breast cancer—or who knows someone who does, is bound to have many questions. Although a qualified healthcare practitioner must be consulted for authoritative answers, […]

close